 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News Merck's Hepatitis C Drug Wins Approval in EuropeMay 23, 2011 After an accelerated review, the European Medicines Agency's Committee for Medicinal Products for Human Use has endorsed Victrelis (boceprevir), Merck's new hepatitis C treatment, and recommended that the European Commission grant marketing approval. The committee said Victrelis should be used in combination with interferon-based treatment in untreated patients with chronic hepatitis C, as well as in patients who had failed on treatment. The action came just a week after the drug was approved by the US Food and Drug Administration. Bloomberg News 05.20.2011  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
 |
Email
Comments
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Site Policies | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
